๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Italy
Clinical trial register · Italy

Studies with an Italian investigative site

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 6830 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:52 UTC
6830
Studies in scope
all four open statuses
4109
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 2849 Bologna 1313 Roma 1277 Naples 984 Rome 980
Narrow the register
Recruitment status
Phase
Lead sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS385 IRCCS Azienda Ospedaliero-Universitaria di Bologna308 AstraZeneca178 IRCCS San Raffaele162 Novartis Pharmaceuticals130
Site location
Milan2849 Bologna1313 Roma1277 Naples984 Rome980
All 483 locations
Target enrolment
to

Trials in this register

6830 of 6830 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Endoscopic Suture Gastroplasty (ESG) for Treatment of Obese Patients With Endometrial Cancer
NCT07397624Endometrial Cancer
Centro di Riferimento Oncologico - Aviano
Observational
74
Aviano, Roma
2026-01-08
By invitation
Intra-operative Hypotension and Post-operative Lactate Level After Pancreatic-duodenectomy
NCT07346274Serum Lactate Post-pancreatic Duodenectomy
Istituto Clinico Humanitas
Observational
60
Milan
2026-01-07
Not yet open
Implementation of an RT-PCR Assay for the Diagnosis of Rickettsia Spp. Infection
NCT07307651Infection, Rickettsia Infections
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
800
Bologna
2026-01-07
Recruiting
TAP Block Versus ESP Block in Patients Undergoing Elective Cesarean Section: a Randomized Controlled Trial
NCT07292662Cesarean Delivery, Regional Anesthesia Block
University of Padova
Not applicable
90
Padova
2026-01-07
Recruiting
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCT07179380Pulmonary Hypertension, Interstitial Lung Disease
DrugTreprostinil Palmitil
Insmed Incorporated
Phase 3
344
Bologna, Milan, Monza, Pavia, Roma, Rozzano, Sassari
2026-01-07
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT07222566Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
DrugsPF-08634404·Pembrolizumab
Pfizer
Phase 3
1,410
Naples, Misterbianco, Meldola, Milan, Fano, Aviano, Roma, Brescia
2026-01-06
Recruiting
Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
NCT07224581GRIN-related Neurodevelopmental Disorder
DrugRadiprodil
GRIN Therapeutics, Inc.
Phase 3
100
Florence, Pavia, Roma
2026-01-05
Recruiting
Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of Hospitalizations
NCT06846879Quality of Care, Evaluation, Emergency Department, Appropriateness
Mario Negri Institute for Pharmacological Research
Observational
240,000
Alessandria, Cuneo, Novara, Novi Ligure, Orbassano, Rivoli, Torino
2026-01-05
Recruiting
Static Balance Assessment in Children With ASD Using VRRS
NCT07403396Autism, Autism Spectrum Disorder
Istituto per la Ricerca e l'Innovazione Biomedica
Observational
50
Messina
2026-01-02
Recruiting
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
NCT07063745Metastatic Non-small Cell Lung Cancer With MTAP Deletion
DrugsNavlimetostat·Nab-paclitaxel·Pemetrexed·Paclitaxel
Bristol-Myers Squibb
Phase 2/3
590
Naples, Ravenna, Aviano, Orbassano, Siena, Perugia, Bologna, Milan
2026-01-02
Recruiting
A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation
NCT07172919Advanced Solid Tumors
DrugsSotorasib·Panitumumab
Amgen
Phase 2
14
Roma
2026-01-02
Recruiting
Feeding Disorders in Children
NCT07431671Neurodevelopmental Disorder (Diagnosis), Feeding Disorder, ARFID
IRCCS San Raffaele Roma
Not applicable
24
Roma
2026-01-01
Recruiting
Skull Fractures in Pediatric Emergency Department: the Ultrasound Protocol
NCT07636902Skull Fractures
Istituto Giannina Gaslini
Not applicable
150
Genova
2026-01-01
Not yet open
Uterine Interstitial Myolisis and Oocytes Retrieval in Single Step: a Pilot Study
NCT07267754Pregnancy Rate IVF, Clinical Pregnancy Rate, Live Birth Rate
San Carlo Public Hospital, Potenza, Italy
Observational
20
Potenza
2026-01-01
Recruiting
CompArative Analysis Between, Thymic, pulmonaRy and Pancreatic Well Differentiated High Grade Neuroendocrine Tumors
NCT07429851Neuroendocrine Carcinoma of Lung, Neuroendocrine Carcinoma of Thymus
European Institute of Oncology
Observational
34
Milan
2026-01-01
By invitation
COLORECTAL CANCER: SINGLE CENTER EXPERIENCE
NCT07576049Colorectal Cancer (Diagnosis)
University of Roma La Sapienza
Observational
37
Roma
2026-01-01
Recruiting
Fecal Microbiota Transplantation to RESCUE Patients With Unresectable Hcc Progressors to First Line Therapy With AtezolizUmaB and Bevacizumab
NCT07276100Hepato Cellular Carcinoma (HCC)
DrugAtezolizumab & Bevacizumab
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase 2
15
Bologna
2026-01-01
Active, closed
DEVELOPMENT OF INNOVATIVE TARGETED LIPOSOMAL FORMULATIONS FOR THE TREATMENT OF INFLAMMATORY DRIVEN PULMONARY FIBROSIS
NCT07571291Pulmonary Fibrosis
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
30
Pavia
2026-01-01
Not yet open
Tridimensional Robotic Assessment of Neglect in Brain Injured Patients
NCT07290218Neglect, Brain Injured Patients, Stroke, Unilateral Spatial Neglect (USN)
Fondazione Don Carlo Gnocchi ETS
Observational
15
Sant'Angelo dei Lombardi, Florence, Pisa
2026-01-01
Recruiting
Reconstruction With a Lawrence-Hunt Jejunal Pouch After Total Gastrectomy
NCT06967571Total Gastrectomy, Gastric Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not applicable
26
Roma
2026-01-01
Recruiting
NAIF 2.0 - COGNIFY
NCT07824297Dural Arteriovenous Fistula, Glymphatic System
Hospital Universitari Vall d'Hebron Research Institute
Observational
20
Bologna
2026-01-01
Not yet open
Inherited Retinal Diseases: Natural History and Genotype-Phenotype Correlations
NCT07265895Retinal Degenerations, Retinitis Pigmentosa (RP), Stargardt Disease
IRCCS San Raffaele
Observational
200
Milan
2026-01-01
Recruiting
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
NCT07140172Breast Cancer
University Hospital, Basel, Switzerland
Not applicable
1,060
Padova, Rome
2026-01-01
Active, closed
COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P)
NCT07455097Intermediate-risk Prostate Cancer, High-risk Prostate Cancer
Heinrich-Heine University, Duesseldorf
Observational
600
Milan
2026-01-01
Not yet open
SOCIAL: Adaptation and Validation of the In-person PEERSยฎ Program for Adolescents With Autism.
NCT07207213Autism Spectrum Disorder
IRCCS Fondazione Stella Maris
Not applicable
36
Calambrone
2026-01-01
Recruiting
Autogenous Tooth Transplantation With Instrumentally Simulated Open Apex and Platelet-Rich Fibrin
NCT07393997Tooth Loss, Tooth Diseases, Reimplant; Complications
University of Bari Aldo Moro
Not applicable
5
Bari
2026-01-01
Not yet open
FMRI Study on DC/TMD Patients
NCT07259902TMJ Disorder
University of Milan
Not applicable
60
Milan
2026-01-01
Recruiting
Oral Health and Systemic Diseases: Survey of General Practitioners
NCT07604493Periodontal Disease, Diabete Mellitus
University of Roma La Sapienza
Observational
100
Roma
2026-01-01
Recruiting
Nerve-SPARing Robotic Prostatectomy: The Impact of Patient Baseline Profiles on Erectile Function
NCT07747272Prostate Cancer, Prostatectomy, Robotic Surgery, Erectile Function
University of Florence
Observational
300
Florence
2026-01-01
Recruiting
Decoding Epigenetic Mechanisms Driving Immune Evasion in Liver Cancer With Omics Approaches
NCT07432347Hepatocarcinoma
Niguarda Hospital
Observational
270
Milan
2026-01-01
Recruiting
Development of an Italian Questionnaire for Splenectomized Patients Using a Delphi Consensus Method
NCT07428005Splenectomy; Status, Asplenia, Splenectomized Patients
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
20
Rome
2026-01-01
By invitation
Autoimmune Hyperthyroidism in Prepubertal Children
NCT07544290Autoimmune Hyperthyroidism, Children
IRCCS Ospedale San Raffaele
Observational
100
Milan
2026-01-01
Not yet open
Prognostic Role of molEcular classiFication in Fertility-sparing treAtment of Endometrial canCEr
NCT06799624Uterine Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Observational
100
Milan
2026-01-01
Not yet open
Physical Exercise to Prevent Mild-cognitive Impairment in Patients With Kidney Disfunctions
NCT07160959Chronic Kidney Disease (Stages 4 and 5), Mild Cognitive Impairment (MCI)
Biogem s.c.ar.l.
Not applicable
124
Ariano Irpino
2026-01-01
Recruiting
Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND)
NCT07360977PARKINSON DISEASE (Disorder), Multiple Sclerosis (MS) - Relapsing-remitting, Pediatric Patients Affected by Neuromuscolar and Degenerative Diseases
IRCCS Centro Neurolesi Bonino Pulejo
Not applicable
300
Messina
2026-01
Not yet open
CardioLogical Interventions and Acute strOke Treatment sTudy
NCT07314476Acute Ischemic Stroke AIS, Stroke Treatment, PCI Patients, Aortic Valve Replacement
University of L'Aquila
Observational
400
Lโ€™Aquila
2026-01
Not yet open
Analysis of the Presence and Cardiac Functional Effects of Anti-NaV1.5 Autoantibodies in Patients With Metastatic Tumors
NCT07364656Brugada Syndrome (BrS), Breast Cancer Females, Colon Cancer, ECG Abnormalities
IRCCS Policlinico S. Donato
Not applicable
196
Milan
2026-01
Not yet open
LANDSCAPE: Demographics and Treatment Patterns of Patients With Immune-Mediated Inflammatory Skin Diseases in Italian Clinical Practice
NCT07336641Psoriasis, Atopic Dermatitis, Vitiligo, Alopecia Areata
Fondazione ISIDE
Observational
20,000
Rozzano
2026-01
Not yet open
Comparison Between Two Medical Devices for the Reconditioning of Lungs Intended for Transplantation
NCT07361718Lung Transplant Surgery
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
20
Bologna
2026-01
Not yet open
Antithrombotic Therapy at the End of Life: The PEACE Study
NCT07338071Palliative Care
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
410
Roma
2026-01
Not yet open
Cost-Effectiveness and Outcome of Robot-assisted Vs Laparoscopic Roux-en-Y Gastric Bypass
NCT07153419Morbid Obesity
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not applicable
512
Roma
2026-01
Not yet open
Neural Correlates of Goal-directed Action Observation and Execution in Children With Unilateral Cerebral Palsy
NCT07369167Cerebral Palsy (CP), Unilateral Cerebral Palsy, EEG, Action Observation
IRCCS Fondazione Stella Maris
Observational
80
Calambrone
2026-01
Recruiting
Prospective Observational Trial of Image-guided Ablative STereotactic bOdy Radiation Therapy for Primary kidNey Cancer: the STONE Trial
NCT07299357Renal Cancer
Istituto Clinico Humanitas
Observational
53
Milan, Rozzano
2026-01
Not yet open
RAPIDE: The Feasibility of a Hybrid Care Model
NCT06735404Diabetes Type 2, Heart Failure
Radboud University Medical Center
Not applicable
180
Verona
2026-01
Not yet open
Proteomic Changes in Patients With Myasthenia Gravis and Ravulizumab
NCT07337395Myasthenia Gravis Generalised
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
24
Roma
2026-01
Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
NCT07221357Untreated, Unresectable, or Metastatic Colorectal Cancer
DrugsFolfiri·Pumitamig·Folfox·Bevacizumab
Bristol-Myers Squibb
Phase 2/3
990
Castellana Grotte, San Giovanni Rotondo, Tricase, Milan, Aviano, Pisa, Padova, Avellino
2025-12-31
Recruiting
Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab.
NCT07330245Lupus Erythematosus, Systemic
DrugAnifrolumab
AstraZeneca
Observational
218
Monserrato, Cona, San Giovanni Rotondo, Rozzano, Ancona, Bari, Brescia, Florence
2025-12-31
Recruiting
LEF1 EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A MARKER FOR DIAGNOSIS AND SURVIVAL PREDICTION
NCT07313982Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
350
Bologna
2025-12-31
Active, closed
Comparing Advanced Hemostasis and Ultrasound-Guided Puncture to Conventional Approaches in Distal Radial Access
NCT06835829Coronary Catheterization
Associazione per lo Studio delle Malattie Cardiovascolari Cardiva ONLUS
Not applicable
480
Roma, Legnago
2025-12-31
Recruiting
PAX5-NEGATIVE HODGKIN-LIKE LYMPHOMAS: A DIAGNOSTIC CHALLANGE
NCT07313943Hodgkin or Non-Hodgkin Lymphoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
60
Bologna
2025-12-30
Recruiting
Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
NCT07288359Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Metastatic Castration-resistant Prostate Cancer
DrugsLetrozole·Fulvestrant
Novartis Pharmaceuticals
Phase 1/2
205
Milan
2025-12-29
Recruiting
A Study to Investigate Bowel Cleansing With PLENVUยฎ Compared to Sodium Picosulfate in Participants Aged 1 to < 18 Years of Age in Preparation for Colonoscopy
NCT07218523Bowel Cleansing Prior to Clinical Procedures
DrugsPicoprep·Plenvu
Norgine
Phase 3
212
Bergamo, Florence, Messina, Milan, Naples, Roma
2025-12-29
Recruiting
Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
NCT07104565Immune Thrombocytopenia
Incyte Corporation
Phase 2
56
Bologna, Brescia, Meldola, Milan, Naples, Padova, Roma
2025-12-29
Recruiting
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
NCT07225569Hidradenitis Suppurativa
Sanofi
Phase 2
144
Torette, Cona, Garbagnate Milanese, Milan, Brescia, Chieti, Pisa
2025-12-29
Recruiting
AZD5335 vs. Mirvetuximab Soravtansine in FRฮฑ-high and AZD5335 vs. Chemotherapy in FRฮฑ-low Platinum-resistant Ovarian Cancer
NCT07218809Epithelial Ovarian Cancer
DrugsTorvutatug samrotecan·MIRV·Mirvetuximab Soravtansine·Pegylated liposomal doxorubicin
AstraZeneca
Phase 3
1,100
Brescia, Catania, Florence, Lecco, Milan, Naples, Parma, Pisa
2025-12-29
Recruiting
USING A DECISION-MAKING SYSTEM TO SUPPORT THE MANAGEMENT OF FEVER AND ACUTE PAIN IN CHILDREN
NCT07344090Fever, Acute Pain
Qwince Innovation S.r.l.
Not applicable
100
Florence
2025-12-28
Recruiting
Adjuvant Treatment in Premenopausal Breast Cancer
NCT06807749Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
800
Roma, Salerno
2025-12-24
Recruiting
Comparison of Bone Mineral Density in the Third Trimester Between Women in Singleton and Twin Pregnancies Using Questionnaires and REMS Densitometric Examination
NCT07508553Osteoporosis, Pregnancy, Twin Pregnancy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not applicable
100
Roma
2025-12-23
Recruiting
Microbiological and Biochemical Profiling of Amniotic Fluid in Women With Short Cervix or Premature Rupture of Membranes
NCT07792083Short Cervix, PROM, Preterm (Pregnancy)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not applicable
300
Roma
2025-12-23
Recruiting
Efficacy of Oral Sucrosomial Iron Supplementation in Children With Celiac Disease and Iron Deficiency or Anemia
NCT07563582Celiac Disease in Children, Anemia, Iron Deficiencies
Istituto Giannina Gaslini
Not applicable
60
Genova
2025-12-23
Recruiting
A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
NCT06932562Multiple Myeloma
DrugsLinvoseltamab·Daratumumab·Lenalidomide·Dexamethasone
European Myeloma Network B.V.
Phase 3
1,000
Ancona, Cuneo, Florence, Genova, Legnano, Meldola, Milan, Reggio
2025-12-23
Recruiting
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
NCT07174336Breast Neoplasms, Neoplasm Metastasis
DrugsTersolisib·Exemestane·Anastrozole·Ribociclib
Eli Lilly and Company
Phase 3
800
Bergamo, Bologna, Florence, Genova, Meldola, Milan, Misterbianco, Monza
2025-12-22
Recruiting
Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)
NCT05962541Non-muscle-invasive Bladder Cancer, Non-Muscle Invasive Bladder Urothelial Carcinoma, High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
University of Roma La Sapienza
Phase 4
327
Rome
2025-12-22
Recruiting
AEF0217 in Participants With Down Syndrome
NCT07334912Down Syndrome (Trisomy 21)
Aelis Farma
Phase 2
188
Bologna, Roma, Troina
2025-12-22
Active, closed
A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
NCT07128199Lung Cancer, Adjuvant, Post-surgical, EGFR
DrugZipalertinib
Taiho Oncology, Inc.
Phase 3
360
Alessandria, Ancona, Bergamo, Bologna, Catania, Meldola, Livorno, Legnano
2025-12-22
Recruiting
A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy
NCT07214753Severe Eosinophilic Asthma
DrugsFasenra·Benralizumab
AstraZeneca
Observational
335
Salerno, Padova, Teramo, Treviso, Varese, Bari, Bergamo, Bologna
2025-12-20
Recruiting
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
NCT07252739Malignant Neoplasm
DrugsCalderasib·Sacituzumab tirumotecan·Cetuximab·Keytruda
Merck Sharp & Dohme LLC
Phase 2
140
Milan
2025-12-19
Recruiting
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
NCT07225946Prostatic Neoplasms, Castration-Resistant
DrugsPasritamig·Prednisone/Prednisolone·Docetaxel
Janssen Research & Development, LLC
Phase 3
800
Florence, Localita La Schiana Pozzuoli, Milan, Roma, Torino
2025-12-19
Recruiting
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
NCT07294170Myasthenia Gravis, MG, gMG, Generalized Myasthenia Gravis
DrugsEmpasiprubart·Efgartigimod
argenx
Observational
70
Bergamo, Milan, Naples
2025-12-19
Recruiting
Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up
NCT07209852Bradycardia, Atrioventricular Block, Sinus Node Dysfunction, Bundle-Branch Block
Boston Scientific Corporation
Observational
140
Ferrara, Milan, Novara
2025-12-19
Recruiting
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
NCT07284420AChR-Ab Seropositive Generalized Myasthenia Gravis, Myasthenia Gravis, MG, gMG
DrugsEmpasiprubart·Efgartigimod
argenx
Phase 2
70
Bergamo, Milan, Naples
2025-12-19
Active, closed
Low Dose Radiotherapy in Primary Indolent Cutaneous B-cell Lymphoma
NCT07310745Primary Indolent Cutaneous B-cell Lymphoma
Azienda USL Reggio Emilia - IRCCS
Observational
52
Reggio Emilia
2025-12-18
Recruiting
Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site
NCT07325864NSCLC, Lung Cancer (Diagnosis)
European Institute of Oncology
Observational
25
Milan
2025-12-18
Recruiting
Ibrutinib Plus Venetoclax Long-Term Outcomes in CLL
NCT07774390Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
European Research Initiative on CLL
Observational
323
Milan
2025-12-18
Recruiting
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
NCT07285460Hemophilia
DrugsAntithrombin·Clotting factor concentrates·Fitusiran
Sanofi
Phase 3
85
Florence, Milan, Rozzano
2025-12-18
Recruiting
A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, in People With a Heart Attack
NCT07301034Myocardial Infarction
DrugZiltivekimab
Novo Nordisk A/S
Phase 3
332
Rome, Bergamo, Messina, Rivoli, Genova, Novara, Orbassano, San Donato Milanese
2025-12-18
Recruiting
Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib
NCT07237256Breast Cancer
UNICANCER
Phase 3
3,902
Aviano, Caserta, Genova, Naples, Padova, Pisa, Pontedera, Roma
2025-12-18
Recruiting
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
NCT07185997Non-Small-Cell Lung Cancer, Metastatic Non-Small-Cell Lung Cancer, Advanced Non-Small-Cell Lung Cancer, EGFR P-Loop and Alpha C-Helix Compressing
DrugFurmonertinib
ArriVent BioPharma, Inc.
Phase 3
480
Aviano, Milan
2025-12-17
Recruiting
VIrtual Reality Induced Pain and anxiEty Relief in Outpatient UROlogical Procedures
NCT07338292Urologic Diseases, Prostate Biopsy, Flexible Cystoscopy, Circumcision
Istituto Oncologico Veneto IRCCS
Not applicable
56
Padova
2025-12-17
Recruiting
A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry
NCT07194070Hemolytic Disease of the Fetus and Newborn
Janssen Research & Development, LLC
Observational
175
Milan, Roma
2025-12-17
Recruiting
WATCHMAN FLX Pro European Registry
NCT07262255Non-valvular Atrial Fibrillation (AF), Left Atrial Appendage Closure
Boston Scientific Corporation
Observational
1,000
Catania, Milan, Verona
2025-12-17
Recruiting
MitrAl Valve Calcium aSsEssmEnt With TrueVue Trans-illumination 3D Rendering.
NCT07612553Mitral Annular Calcification, Mitral Valve Disease
Centro Cardiologico Monzino
Observational
100
Milan
2025-12-17
Recruiting
Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe HS Within the Italian Population
NCT07543419Hidradenitis Suppurativa
Novartis Pharmaceuticals
Observational
250
Ancona, Bari, Brescia, Cona, Florence, Genova, Lecce, Messina
2025-12-17
Recruiting
Gingival Phenotype and Dental Crowding in Pediatric Patients
NCT07205172Crowding, Tooth, Gingival Diseases
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
180
Roma
2025-12-16
Not yet open
Efficacy and Safety of 7 Millimeters Vaginal Radiofrequency in Overactive Bladder
NCT07279142Overactive Bladder (OAB), Incontinence, Urge
IRCCS San Raffaele
Not applicable
48
Milan
2025-12-16
Active, closed
Central Sensitisation in Nociceptive and Neuropathic Pain
NCT07321080Chronic Pain, Nociceptive Pain, Neuropathic Pain, Mixed Pain (Nociceptive and Neuropathic)
IRCCS Centro Neurolesi Bonino Pulejo
Observational
185
Messina
2025-12-15
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
NCT07252232Pancreatic Cancer, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma (PDAC)
DrugCetuximab
Revolution Medicines, Inc.
Phase 3
500
Milan, Padova, Pisa, Verona
2025-12-15
Recruiting
Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.
NCT07107529Multiple Myeloma (MM)
DrugsTalquetamab·Teclistamab·Daratumumab
European Myeloma Network B.V.
Phase 2
150
Ascoli Piceno, Bari, Bergamo, Bologna, Bolzano, Como, Milan, Novara
2025-12-12
Recruiting
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
NCT07221851Turner Syndrome, Short Stature Homeobox Gene Mutation, Idiopathic Short Stature, Small for Gestational Age at Delivery
Ascendis Pharma A/S
Phase 3
186
Florence, Naples, Trieste
2025-12-12
Recruiting
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in IBC
NCT07080944Invasive Breast Carcinoma, Sentinel Lymph Node Biopsy (SLNB), Neoadjuvant Chemotherapy
European Institute of Oncology
Not applicable
75
Milan
2025-12-12
Recruiting
A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)
NCT07221474Squamous Non-small Cell Lung Cancer
DrugsIntismeran autogene·Nab-paclitaxel·Keytruda·Paclitaxel
Merck Sharp & Dohme LLC
Phase 2
180
Ravenna, Milan, Roma
2025-12-12
Recruiting
ESOTIP-TEE: Defining an Easy Landmark to Guide Correct Esophageal Probe Placement With Transesophageal Echocardiography
NCT07574736Monitoring, Esophageal Temperature, Hypothermia
Institute of Mountain Emergency Medicine
Observational
30
Merano
2025-12-12
Not yet open
Extracorporeal Therapy and Therapeutic Drug Monitoring
NCT07287813ICU Patients With ECMO And-or RRT and With Gram Negative Infections Susceptible to BL-BLIs
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
40
Pavia
2025-12-12
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
DrugsVepugratinib·Pembrolizumab
Eli Lilly and Company
Phase 3
450
Bari, Milan, Naples, Padova, Pisa, Roma, Rome
2025-12-12
Recruiting
New Care Pathways for Supporting TRANSitional CARE From Hospital to Home Using AI and Personalized Digital Assistance
NCT07731126Transitional Care, Remote Patient Monitoring (RPM), Geriatric Multimorbidity
Istituto Nazionale di Ricovero e Cura per Anziani
Not applicable
210
Ancona
2025-12-12
Recruiting
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
NCT07222800Intestinal Neoplasms, Gastrointestinal Neoplasms, Digestive System Neoplasms, Neoplasms by Site
DrugsPF-08634404·Avastin·Bevacizumab
Pfizer
Phase 3
800
Tricase, Roma, Padova, Milan
2025-12-11
Recruiting
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
NCT07222267Breast Cancer, Advanced Solid Tumor
DrugBG-75202
BeOne Medicines
Phase 1
86
Milan, Naples, Roma, Rozzano
2025-12-11
Recruiting
Combined Use of PRP and Hyaluronic Acid for Infiltrative Treatment of Patients With Knee Osteoarthritis
NCT06685120Osteo Arthritis Knee
Istituto Ortopedico Rizzoli
Not applicable
288
Bologna
2025-12-11
Recruiting
DCEUS to Assess Treatment Response to PRRT in GEP-NET
NCT07319416NET, Radionucleide Therapy, Contrast Enhanced Ultrasound
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not applicable
30
Rome
2025-12-11
Recruiting
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
NCT07144163Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia
DrugAtumelnant
Crinetics Pharmaceuticals Inc.
Phase 3
150
Genova, Milan, Rozzano, Modena, Padova, Palermo, Naples, Roma
2025-12-11
Rows per page Showing 901–1000 of 6830
Previous 8 9 10 11 12 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-italy?page=10

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,830 studies in total at the last sync on 26 Sep 2026, 19:52 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in Italy?

4,109 of the 6,830 studies in this register are recruiting new participants as of the 26 Sep 2026, 19:52 UTC sync. A further 587 have not yet opened recruitment, 1,928 are active but closed to new participants, and 206 are enrolling by invitation only. Eligibility for any study is decided by its study team.

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Breast Cancer (164) Heart Failure (67) Parkinson Disease (66) Multiple Sclerosis (57) Multiple Myeloma (57) Prostate Cancer (57) Stroke (55) Ovarian Cancer (54) Obesity (48) Colorectal Cancer (43) Coronary Artery Disease (42) Non-Small Cell Lung Cancer (40) Non-small Cell Lung Cancer (39) Carcinoma, Non-Small-Cell Lung (36) Ulcerative Colitis (36)
→

Browse trials by site location

Milan (2849) Bologna (1313) Roma (1277) Naples (984) Rome (980) Florence (787) Pavia (566) Brescia (526) Padova (495) Genova (482) Rozzano (473) Bari (439) Pisa (393) Bergamo (373) Meldola (356)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.